Literature DB >> 30725423

Is the Hoffman Effect for Methionine Overuse Analogous to the Warburg Effect for Glucose Overuse in Cancer?

Robert M Hoffman1,2.   

Abstract

The general cancer-specific metabolic defect of methionine (MET) dependence is due to MET overuse for aberrant transmethylation reactions. The excess use of MET for aberrant transmethylation reactions apparently diverts methyl groups from DNA. The resulting global DNA hypomethylation is also a general phenomenon in cancer and leads to unstable genomes and aneuploid karyotypes. The excessive and aberrant use of MET in cancer is readily observed in [11C]-MET-PET imaging, where high uptake of [11C]-MET results in a very strong and selective tumor signal compared to normal tissue background for brain cancer and possibly other cancers. [11C]-MET is superior to [18C]-fluorodeoxyglucose (FDG) for PET imaging, suggesting that MET overuse in cancer ("Hoffman effect") is greater than glucose overuse in cancer ("Warburg effect").

Entities:  

Keywords:  Cellular methionine; DNA methylation; Hoffman effect; Methionine dependence; S-Adenosylmethionine; Transmethylation

Mesh:

Substances:

Year:  2019        PMID: 30725423     DOI: 10.1007/978-1-4939-8796-2_21

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

Review 1.  Targeting the methionine addiction of cancer.

Authors:  Joni C Sedillo; Vincent L Cryns
Journal:  Am J Cancer Res       Date:  2022-05-15       Impact factor: 5.942

Review 2.  Interactions between Radiation and One-Carbon Metabolism.

Authors:  Navyateja Korimerla; Daniel R Wahl
Journal:  Int J Mol Sci       Date:  2022-02-08       Impact factor: 5.923

Review 3.  Efficacy of Recombinant Methioninase (rMETase) on Recalcitrant Cancer Patient-Derived Orthotopic Xenograft (PDOX) Mouse Models: A Review.

Authors:  Kei Kawaguchi; Qinghong Han; Shukuan Li; Yuying Tan; Kentaro Igarashi; Takashi Murakami; Michiaki Unno; Robert M Hoffman
Journal:  Cells       Date:  2019-05-02       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.